Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of raw Pinellia ternate in treating esophageal cancer

被引:0
|
作者
Liu, Yanxin [1 ]
Bai, Yunfei [1 ]
Zhang, Jinbang [1 ]
Silva-Filho, Reginaldo [2 ]
Zhu, Qingchun [1 ]
Lei, Zhen [3 ]
机构
[1] Henan Univ Tradit Chinese Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Dept Pharm, 6 Dongfeng Rd, Zhengzhou 450053, Peoples R China
[2] Fac EBRAMEC, Sao Paulo, Brazil
[3] Henan Univ Tradit Chinese Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Cent Lab, Zhengzhou, Peoples R China
关键词
Raw Pinellia ternata (RP); esophageal cancer (EC); network pharmacology; PI3K-Akt signal pathway; PI3K/AKT SIGNALING PATHWAY; ACTIVATION; APOPTOSIS;
D O I
10.21037/jgo-23-684
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Esophageal cancer (EC) is a highly lethal malignancy with a grim prognosis and high mortality rates, primarily treated through surgery and radiotherapy. Herbal remedies are emerging as complementary approaches in cancer therapy. Here, we explore the potential therapeutic benefits of Chinese medicine raw Pinellia ternata (RP) in EC using web-based pharmacological methods and cellular experiments.Methods: The chemical components of RP were obtained by data mining via searches of the systematic pharmacology database, analysis platform, and literature on traditional Chinese medicine (TCM). The properties of the main components of RP were calculated using Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). The potential targets of the components were mined and collected through multiple databases, and the relevant potential targets of efficacy were imported into Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database to obtain protein interactions. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathway enrichment analysis of the potential targets were performed through Metascape. A target-pathway network was established using Cytoscape, and topological analysis was performed on the network so as to obtain the relevant targets and pathways of RP in the treatment of EC. The inhibitory effect of RP on human EC cells was verified by cell experiments.Results: Thirteen bioactive components of RP were screened, 87 related targets were obtained by construction, and 68 co-targets were obtained after taking intersection with EC related genes. The results of the protein-protein interaction (PPI) network analysis of the targets showed that the pharmacodynamic targets of hemicellulose might be closely related to the signaling pathways such as PI3K-Akt, FOS/JUN, and HIF-1. Meanwhile, GO and KEGG enrichment analysis showed that PI3K-Akt was also significantly enriched. The in vitro cellular experiments further indicated that raw hemicrania could inhibit EC through the PI3K-Akt signaling pathway. Conclusions: The pharmacodynamic mechanism of RP in the treatment of esophageal carcinoma was preliminarily revealed, which provided ideas and the basis for further experimental study of RP in the treatment of esophageal carcinoma.
引用
收藏
页码:2006 / 2017
页数:14
相关论文
共 50 条
  • [1] Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia
    Wang, Liang
    Wang, Peng
    Chen, Yingfan
    Li, Chen
    Wang, Xuelin
    Zhang, Yin
    Li, Shaodan
    Yang, Minghui
    BIOENGINEERED, 2022, 13 (02) : 3148 - 3170
  • [2] Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer
    Zhang, Zhiqiang
    Zhou, Jiayi
    Guo, Ruiqian
    Zhou, Qijun
    Wang, Lianzhi
    Xiang, Xingyan
    Ge, Sitong
    Cui, Zhezhu
    MEDICINE, 2023, 102 (45) : E34871
  • [3] Utilizing network pharmacology to explore potential mechanisms of YiSui NongJian formula in treating myelodysplastic syndrome
    Qin, Lerong
    Chen, Haiyan
    Ding, Xiaoqing
    Guo, Ming
    Lang, Haiyan
    Liu, Junxia
    Li, Ling
    Liao, Jing
    Liao, Junyao
    BIOENGINEERED, 2021, 12 (01) : 2238 - 2252
  • [4] Integrated Network Pharmacology, Molecular Docking, and Experimental Validation to Explore Potential Mechanisms of Sinomenine in the Treatment of Osteoarthritis
    Wang, Shaojun
    Lai, Fanglin
    Xiang, Ting
    Xu, Yan
    NATURAL PRODUCT COMMUNICATIONS, 2024, 19 (07)
  • [5] Utilizing Network Pharmacology and Molecular Docking Technology to Explore The Potential Molecular Mechanisms of Xue Fu Zhu Yu Tang In Treating Insomnia
    Zheng, Junping
    Doblas, Glenda Z.
    PROCEEDINGS OF 2024 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND INTELLIGENT COMPUTING, BIC 2024, 2024, : 183 - 190
  • [6] Network Pharmacology and Experimental Validation Explore the Pharmacological Mechanisms of Herb Pair for Treating Rheumatoid Arthritis
    Xu, Xi-Xi
    Shao, Hua
    Wang, Qiao-Xue
    Wang, Zi-Yuan
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (12) : 1808 - 1822
  • [7] Exploring the Potential Antidepressant Mechanisms of Pinellia by Using the Network Pharmacology and Molecular Docking
    Xiao, Yu-Gang
    Wu, Han-Biao
    Chen, Ji-Sheng
    Li, Xiong
    Qiu, Zhi-Kun
    METABOLIC BRAIN DISEASE, 2022, 37 (04) : 1071 - 1094
  • [8] Exploring the Potential Antidepressant Mechanisms of Pinellia by Using the Network Pharmacology and Molecular Docking
    Yu-Gang Xiao
    Han-Biao Wu
    Ji-Sheng Chen
    Xiong Li
    Zhi-Kun Qiu
    Metabolic Brain Disease, 2022, 37 : 1071 - 1094
  • [9] Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne
    Di, Huifeng
    Liu, Hui
    Xu, Shuna
    Yi, Na
    Wei, Guangchen
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 39 - 53
  • [10] Network Pharmacology and Experimental Validation to Explore the Potential Mechanism of Nigella sativa for the Treatment of Breast Cancer
    Arif, Rawaba
    Bukhari, Shazia Anwer
    Mustafa, Ghulam
    Ahmed, Sibtain
    Albeshr, Mohammed Fahad
    PHARMACEUTICALS, 2024, 17 (05)